Skip to main content
Alligator Bioscience logo

Alligator Bioscience — Investor Relations & Filings

Ticker · ATORX ISIN · SE0024173637 LEI · 549300E15VI0MB7LXV19 ST Manufacturing
Open in API
Filings indexed 612 across all filing types
Latest filing 2021-04-26 AGM Information
Country SE Sweden
Listing ST ATORX

About Alligator Bioscience

https://alligatorbioscience.se/en/

Alligator Bioscience is a clinical-stage biotechnology company that develops tumor-directed immuno-oncology antibody drugs. The company's core strategy is to activate the patient's own immune system to fight cancer. It utilizes a proprietary technology platform for the discovery and development of novel antibody-based pharmaceuticals. The development pipeline features several drug candidates, including its lead asset mitazalimab, a CD40 agonist. The company specializes in creating therapeutics that are designed to be effective against various forms of cancer.

Recent filings

Filing Released Lang Actions
Kallelse till årsstämma i Alligator Bioscience AB
AGM Information Classification · 1% confidence The document is titled "Kallelse till årsstämma i Alligator Bioscience AB" (Notice of Annual General Meeting in Alligator Bioscience AB) and explicitly states that shareholders are being called to the Annual General Meeting (årsstämma) on June 1, 2021. It details the procedures for participation via advance voting (poströstning) due to COVID-19, outlines the proposed agenda (including election of the board, approval of financial statements, and remuneration), and presents specific proposals for shareholder votes. This content is characteristic of a formal notice and agenda for an Annual General Meeting.
2021-04-26 Swedish
Notice of annual general meeting in Alligator Bioscience AB
AGM Information Classification · 1% confidence The document is explicitly titled "Notice of annual general meeting in Alligator Bioscience AB" and invites shareholders to attend the meeting via advance voting. The agenda items cover standard AGM topics such as election of the Chairman, approval of the register of voters, election of board members and auditors, determination of remuneration, and resolutions on profit distribution and incentive programs. This content is characteristic of materials prepared for and distributed before an Annual General Meeting (AGM). Although it mentions the Annual Report and Audit Report under Item 7, the document itself is the formal notice and proposal document for the meeting, making 'AGM-R' (AGM Information) the most appropriate classification, as it contains the proposals and procedural details for the meeting.
2021-04-26 English
Valberedningens förslag till styrelse inför årsstämman 2021 i Alligator Bioscience AB
AGM Information Classification · 1% confidence The document is titled 'Valberedningens förslag till styrelse inför årsstämman 2021 i Alligator Bioscience AB' (The Nomination Committee's proposal for the Board of Directors ahead of the 2021 Annual General Meeting). It explicitly details the proposed composition of the Board of Directors, including nominations for Chairman and Vice Chairman, and lists current members who have declined re-election. This content directly relates to the governance and composition of the board, which is a key component of materials presented or discussed during an Annual General Meeting (AGM). While it is a proposal *for* the AGM, the specific focus on board nominations and composition aligns most closely with the context of AGM materials or governance disclosures. Since it is a proposal *for* the AGM, and not the final voting results (DVA) or a general governance report (CGR), it fits best under AGM-R, which covers presentations and materials shared during the AGM. The document is not a general announcement of the meeting itself, but the substance of a key proposal to be voted on.
2021-04-22 Swedish
The Nomination Committee’s proposal regarding the board of directors ahead of the annual general meeting 2021 in Alligator Bioscience AB
Board/Management Information Classification · 1% confidence The document explicitly discusses the 'Nomination Committee's proposal regarding the board of directors ahead of the annual general meeting 2021'. It details proposed re-elections and new appointments for the board, including the Chairman and Vice Chairman, and provides biographies for the proposed new members. This content directly relates to the composition and governance structure of the board, which falls under Board/Management Information (MANG) or potentially Governance Information (CGR). However, the focus is specifically on the *change* in management/board composition proposed for the upcoming AGM, making MANG the most precise fit, as it covers 'Announcement of changes in the company's board of directors or senior management.' While it is related to the AGM, it is not the AGM presentation itself (AGM-R) or the proxy materials (PSI), but the proposal leading up to it.
2021-04-22 English
Alligator Bioscience flyttar fram årsstämman till 1 juni 2021
Report Publication Announcement Classification · 1% confidence The document is a press release announcing a change in the date and format (moving to postal voting only due to COVID-19) of the company's Annual General Meeting (Årsstämma). The key phrase is 'flyttar fram årsstämman' (postpones the annual general meeting). This relates directly to the AGM proceedings. Since the document is an announcement about the meeting logistics rather than the voting results (DVA) or the proxy materials themselves (PSI), the most appropriate classification is AGM Information (AGM-R), as it pertains to the meeting itself.
2021-04-03 Swedish
Alligator Bioscience postpones the Annual General Meeting to June 1, 2021
AGM Information Classification · 1% confidence The document explicitly announces the postponement of the 'Annual General Meeting' (AGM) date and details procedural changes (voting by advance ballot due to Covid-19). While it discusses the AGM, it is an announcement *about* the meeting logistics and scheduling, not the presentation materials (AGM-R) or the proxy solicitation materials (PSI). Since the core subject is the scheduling and procedural update related to the AGM, and there is no specific code for 'AGM Announcement', the most fitting category is 'AGM-R' (AGM Information), as this category often encompasses related announcements surrounding the meeting, or 'RNS' (Regulatory Filings) as a general announcement. Given the specific mention of the AGM, AGM-R is preferred over the generic RNS, as it directly relates to the event being managed. The document is short and is an announcement, but it is announcing the event itself, not just the publication of a separate report.
2021-04-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.